Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapyMelody Smith, Marco Ruella, John Slingerland et al.|Nature Medicine|2022Cited by 308
Modulation of BCL-2 in Both T Cells and Tumor Cells to Enhance Chimeric Antigen Receptor T-cell Immunotherapy against CancerYong Gu Lee, Marco Ruella, Puneeth Guruprasad et al.|Cancer Discovery|2022Cited by 98
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapyMireia Uribe‐Herranz, Andrea Facciabene, Silvia Beghi et al.|Molecular Therapy|2023Cited by 57